Real-World Effectiveness, Safety, and Adverse Event Kinetics of Pembrolizumab in Advanced Melanoma within the Brazilian Public Health System
Journal of Oncology Pharmacy Practice
Published online on February 05, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionMelanoma, though relatively rare, is the most aggressive form of skin cancer due to its high metastatic potential and mortality rate. Immunotherapy, such as pembrolizumab, has improved outcomes for patients. However, access to these therapies ...
IntroductionMelanoma, though relatively rare, is the most aggressive form of skin cancer due to its high metastatic potential and mortality rate. Immunotherapy, such as pembrolizumab, has improved outcomes for patients. However, access to these therapies ...